PHA-Exchange> The Drugs for Neglected Diseases Initiative

[Claudio]

From: Ruggiero, Mrs. Ana Lucia (WDC) 

DNDi, the Drugs for Neglected Diseases Initiative:
A global initiative to develop drugs for those in needDNDi website: http://www.accessmed-msf.org/dnd/dndi.asp 


"....The Drugs for Neglected diseases Initiative from Médecins Sans Frontières' Drugs for Neglected Diseases Working Group. The DNDi aims to take the development of drugs for neglected diseases out of the marketplace and encourage the public sector to assume greater responsibility. It aspires to harness public and private sector resources with new science and technology, to meet a needs-based research and development agenda for drugs for neglected disease. 



This is reflected in the constitution of its Founding Partners that currently include Médecins Sans Frontières, WHO/TDR, Oswaldo Cruz Foundation/ Far Manguinhos (Brazil), the Indian Council of Medical Research (India), Institut Pasteur (France), and the Ministry of Health (Malaysia). An additional Founding Partner will be identified within the African DNDi network, while efforts are also underway to ensure patient representation. 



The initiative will catalyse and coordinate research and manage drug development projects. It will outsource most R&D activities - from discovery through predevelopment to development, including clinical trials - while maintaining leadership over the process.



Their mission: To improve the health and quality of life of people suffering from neglected diseases by emphasizing the importance of public responsibility in the development of appropriate drugs for these diseases, and equitable access to these drugs. ...."



-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://phm.phmovement.org/pipermail/phm-exchange-phmovement.org/attachments/20030826/c1a6d8e2/attachment-0001.html>